ArticlebioRxiv : the preprint server for biology2026

Development of GS-441524 Derivatives as Potent SARS-CoV-2 Mac1 Inhibitors via a Direct-to-Biology Approach.

Kewen Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.